Communicable Disease News and Research

RSS

Communicable Disease is a disease capable of being transmitted from an infected person or species to a susceptible host.

The potential influence of pre-existing parasitic infections on COVID-19 morbidity

The study reveals that countries with a high malaria prevalence have a lower incidence of COVID-19.

13 Oct 2022

UW Medicine identifies a case of Legionella pneumonia

A patient treated in September at UW Medical Center-Montlake was diagnosed with Legionella pneumonia presumed to be a healthcare-associated infection.

7 Oct 2022

What is the SARS-CoV-2 transmissibility among United States residents?

In a new study, researchers estimated region-specific basic reproduction number (R0) values for metropolitan statistical areas in the US, based on compartmental modeling with reproduced SARS-CoV-2 surveillance data.

20 Sep 2022

The associations between vaccination status, type, and time since vaccination with lineage identity during the emergence of new SARS-CoV-2 variants

Researchers assessed the association between SARS-CoV-2 strains and patient age, COVID-19 vaccination status, vaccine type, and days elapsed since the most recent vaccination among New York residents.

7 Sep 2022

What are the risk factors related to COVID-19-related hospitalization and mortality?

In a new study, researchers assessed the risk factors associated with COVID-19-related hospitalization or mortality.

16 Aug 2022

Fighting monkeypox, sexual health clinics are underfunded and ill-equipped

Clinics that treat sexually transmitted diseases — already struggling to contain an explosive increase in infections such as syphilis and gonorrhea — now find themselves on the front lines in the nation's fight to control the rapidly growing monkeypox outbreak.

19 Jul 2022

Lipids in breastmilk may protect against metabolic disease later in life

A new study examines the lipid content in breastmilk and its association with NCDs later in life.

13 Jul 2022

Study finds Omicron variant could break through vaccine protection more effectively than the Delta variant

Researchers assessed the efficacy of vaccinations against SARS-CoV-2 Delta and Omicron variants of concern.

29 Jun 2022

Potential new approach could make Japanese encephalitis vaccine more affordable

A potential new approach to administering an existing Japanese encephalitis (JE) vaccine could make it more affordable and increase dose numbers in Australia.

31 Mar 2022

Pandemic funding is running out for community health workers

As a community health worker, 46-year-old Christina Scott is a professional red-tape cutter, hand-holder, shoulder to cry on, and personal safety net, all wrapped into one.

31 Mar 2022

Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

A recent study investigated the potency and functionality of T-cell and humoral responses against the SARS-CoV-2 wild-type strain and its variants.

28 Mar 2022

New approach to help low- and middle-income countries reduce premature mortality from NCDs

Most of the world's countries have made little progress towards a target adopted by the United Nations in 2015, which called for the world to reduce premature mortality from non-communicable diseases by a third by 2030.

27 Mar 2022

Socioeconomic deprivation is a risk factor for premature cardiovascular mortality, study suggests

People living in socially-deprived areas of the United States are more likely to die prematurely from cardiovascular (CV) complications according to new research published recently in Mayo Clinic Proceedings.

15 Mar 2022

Genetic sequencing may be a valuable tool to help identify geographic HIV transmission patterns

Sexual partnerships between individuals from different communities may help explain why some community-based HIV prevention efforts were moderately effective, shows a study published in eLife.

8 Mar 2022

Researchers highlight the extent to which NAFLD and diabetes jointly occur worldwide

Non-alcoholic fatty liver disease (NAFLD) has become an epidemic, similar to the non-communicable diseases cancer, obesity, cardiovascular disease and diabetes.

18 Feb 2022

Omicron variant's 'milder' outcomes may be due to more population immunity

The SARS-CoV-2 Omicron variant's "milder" outcomes are likely due to more population immunity compared to earlier waves of the pandemic rather than the virus's properties, according to a paper by William Hanage, associate professor of epidemiology and co-director of the Center for Communicable Disease Dynamics at Harvard T.H. Chan School of Public Health, and Roby Bhattacharyya, assistant professor at Massachusetts General Hospital and Harvard Medical School and associate member at the Broad Institute of MIT and Harvard.

2 Feb 2022

Communicable Disease News and Research

The potential influence of pre-existing parasitic infections on COVID-19 morbidity

UW Medicine identifies a case of Legionella pneumonia

What is the SARS-CoV-2 transmissibility among United States residents?

The associations between vaccination status, type, and time since vaccination with lineage identity during the emergence of new SARS-CoV-2 variants

What are the risk factors related to COVID-19-related hospitalization and mortality?

Fighting monkeypox, sexual health clinics are underfunded and ill-equipped

Lipids in breastmilk may protect against metabolic disease later in life

Study finds Omicron variant could break through vaccine protection more effectively than the Delta variant

Potential new approach could make Japanese encephalitis vaccine more affordable

Pandemic funding is running out for community health workers

Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

New approach to help low- and middle-income countries reduce premature mortality from NCDs

Socioeconomic deprivation is a risk factor for premature cardiovascular mortality, study suggests

Genetic sequencing may be a valuable tool to help identify geographic HIV transmission patterns

Researchers highlight the extent to which NAFLD and diabetes jointly occur worldwide

Omicron variant's 'milder' outcomes may be due to more population immunity

More is better than less when it comes to physical activity and cardiovascular disease

Exploring immunogenicity and safety after a homologous booster dose of SARS-CoV-2 recombinant spike protein vaccine

Tobacco-style health campaigns are required to spell out the harms of ultra processed foods

How LA, calling the shots on school vaccine mandates, can lead the way on covid rules

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News